Παρακαλώ χρησιμοποιήστε αυτό το αναγνωριστικό για να παραπέμψετε ή να δημιουργήσετε σύνδεσμο προς αυτό το τεκμήριο:
https://hdl.handle.net/10442/18691
Εξειδίκευση τύπου : | Άρθρο σε επιστημονικό περιοδικό |
Τίτλος: | Dendrimers in Alzheimer's Disease: Recent Approaches in Multi-Targeting Strategies |
Δημιουργός/Συγγραφέας: | [EL] Αρμπέζ-Ζιντρ, Σεσίλ[EN] Arbez-Gindre, Cecile [EL] Στηλ, Μπάρυ[EN] Steele, Barry R. [EL] Μίχα-Σκρέττα, Μαρία[EN] Micha-Screttas, Maria |
Εκδότης: | MDPI |
Ημερομηνία: | 2023-03-10 |
Γλώσσα: | Αγγλικά |
ISSN: | 1999-4923 |
DOI: | 10.3390/pharmaceutics15030898 |
Άλλο: | 36986759 |
Περίληψη: | Nanomaterials play an increasingly important role in current medicinal practice. As one of the most significant causes of human mortality, and one that is increasing year by year, Alzheimer's disease (AD) has been the subject of a very great body of research and is an area in which nanomedicinal approaches show great promise. Dendrimers are a class of multivalent nanomaterials which can accommodate a wide range of modifications that enable them to be used as drug delivery systems. By means of suitable design, they can incorporate multiple functionalities to enable transport across the blood-brain barrier and subsequently target the diseased areas of the brain. In addition, a number of dendrimers by themselves often display therapeutic potential for AD. In this review, the various hypotheses relating to the development of AD and the proposed therapeutic interventions involving dendrimer-base systems are outlined. Special attention is focused on more recent results and on the importance of aspects such as oxidative stress, neuroinflammation and mitochondrial dysfunction in approaches to the design of new treatments. |
Τίτλος πηγής δημοσίευσης: | Pharmaceutics |
Τόμος/Κεφάλαιο: | 15 |
Τεύχος: | 3 |
Θεματική Κατηγορία: | [EL] Νανοτεχνολογία[EN] Nanotechnology [EL] Χημεία (Γενικά)[EN] Chemistry (General) [EL] Χημική Βιολογία[EN] Chemical Biology [EL] Φαρμακευτική χημεία[EN] Pharmaceutical chemistry |
Λέξεις-Κλειδιά: | Alzheimer’s disease Aβ amyloid Blood–brain barrier Dendrimers Drug delivery Mitochondrial Dysfunction Neuroinflammation Oxidative stress Tau protein |
Κάτοχος πνευματικών δικαιωμάτων: | © 2023 by the authors. Licensee MDPI, Basel, Switzerland. |
Όροι και προϋποθέσεις δικαιωμάτων: | This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). |
Ηλεκτρονική διεύθυνση στον εκδότη (link): | https://www.mdpi.com/1999-4923/15/3/898 |
Εμφανίζεται στις συλλογές: | Ινστιτούτο Χημικής Βιολογίας - Επιστημονικό έργο
|